Receptor-gated calcium channel (ROCC)

Receptor-gated calcium channels, also known as ligand-gated calcium channels or receptor-operated calcium channels (ROCCs), are a diverse group of transmembrane proteins that facilitate the influx of calcium ions into the cell in response to the binding of specific chemical ligands [1, 13]. Unlike voltage-gated channels, these receptors are directly or indirectly gated by neurotransmitters such as glutamate and ATP, or by intracellular second messengers like inositol trisphosphate (IP3) [4, 20]. The primary members of this class include the N-methyl-D-aspartate (NMDA) receptor, P2X receptors, and IP3 receptors, each playing vital roles in signal transduction, synaptic plasticity, and muscle contraction [2, 11]. Under physiological conditions, they regulate intracellular calcium homeostasis and drive essential signaling cascades that influence gene expression and cellular survival [5, 9]. However, excessive activation of these channels can lead to calcium overload and excitotoxicity, which is a major pathological mechanism in neurodegenerative diseases like Alzheimer's and Parkinson's, as well as in acute conditions like stroke [1, 16]. Consequently, these channels are significant therapeutic targets; for example, NMDA receptor antagonists like memantine and ketamine are used clinically to treat dementia and depression by modulating calcium-mediated neurotransmission [2, 4].

Other names

Ligand-gated calcium channelReceptor-operated calcium channelROCROCCIonotropic calcium channelLigand-gated ion channel (calcium-permeable)

Drugs targeting these channels typically act as non-competitive channel blockers, competitive antagonists, or allosteric modulators to inhibit excessive calcium influx; occasionally, agonists or potentiators are used to enhance deficient signaling [2, 4, 12].